By
AmyT on
November 28, 2012
To my mind, the DiabetesMine Innovation Summit I’ve hosted the last two years is not a “conference.” Rather, in the true tradition of a “Summit,” it aims to bring key decision-makers and other folks passionate about diabetes care together in one room for some very frank conversations about where we are now, what needs improvement, and how we can get to a better place as quickly as possible.
On that note, the Pharma executives and…
Read more »
For as long as there has been research to cure diabetes, there have been people who believe that a cure will never happen because treating this disease is simply far too profitable. Those who believe in this so-called “conspiracy theory” are convinced that pharma companies have a vested interest in keeping diabetes around as long as possible because peddling their treatments is far bigger business than a cure could ever be.
We all know that…
Read more »
By
AmyT on
September 26, 2012
This past Sunday through Tuesday, the legendary Joslin Diabetes Center hosted its first-ever “Diabetes + Innovation” conference at the Crystal City Hyatt hotel in Arlington, VA. (They tell us this DC location was more convenient for the many government and large healthcare orgs participating than Joslin’s home base in Boston.)
As you might imagine, no one could have been more excited than I about the world’s leading diabetes clinic organizing a high-level conference on INNOVATION…
Read more »
By
WilD on
August 22, 2012
It looks like a duck. It quacks like a … Oh. Wait a minute. It doesn’t quack at all. So why is Abbott Diabetes calling it a duck? (That’s a metaphorical question, just so you know.)
The metaphoric duck we’re talking about lives over in Europe and is quacking along just fine. Its real name is the Abbott Freestyle InsuLinx glucose meter, and it was introduced in Europe in May 2011 and Canada this May,…
Read more »
